Bruno Fant

Bruno Fant has a strong background in molecular biology and genetics with experience as a postdoctoral scientist in neuroscience. With a Master's degree in Complex Systems and Biologie moléculaire, Bruno has worked as a bioinformatician and large dataset molecular biology consultant. Currently serving as the Chief Technology Officer at myNEO Therapeutics, Bruno is leading the development of breakthrough immunotherapies to combat cancer by targeting novel tumor targets found in the dark genome.